← TrialMatch
HomeTrials

OUTcomes Evaluation of Current Therapeutic STrategies for Severe Aortic Valve steNosis anD

In 2015 the Italian Ministry of Health invited the Cardiac Research Hospitals of Italy to constitute a Cardiac Network. The aim of the network is to facilitate and promote scientific and technological research in the setting of cardiovascular diseases and related risk factors. IRCCS (Scientific Research and Cure Instit

Condition(s)Aortic Valve Stenosis
StatusRecruiting
Study typeObservational
SummaryIn 2015 the Italian Ministry of Health invited the Cardiac Research Hospitals of Italy to constitute a Cardiac Network. The aim of the network is to facilitate and promote scientific and technological research in the setting of cardiovascular diseases and related risk factors. IRCCS (Scientific Research and Cure Institute) Policlinico San Donato is the responsible hospital for cardiac valve pathologies and has been appointed the leader for the present study. The non-calcific aortic valve stenosis in the elderly is one of the most frequent cardiovascular diseases. Different therapeutic options are available for treating this condition: medical therapy and follow-up, conventional surgery (including sternotomy and employment of mechanical, biological, or sutureless valves), and transcatheter
Who can participateInclusion Criteria: * age higher or equal to 65 years; * aortic valve stenosis that, according to current guidelines, should be treated by a valve replacement; * written consent to participate. Exclusion Criteria: * aortic valve insufficiency not due to stenosis; * refusal to participate.
Ages65 Years
SexAll
Lead sponsorIRCCS Policlinico S. Donato
LocationsSan Donato Milanese, MI, Italy
Start date2018-11-01
NCT IDNCT05778773
Official listinghttps://clinicaltrials.gov/study/NCT05778773

🔍 Search all trials →